Gene · 708
Papers2,456
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,456
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Archaeometric Analyses of Medieval Pottery from the Lower Danube Region, Romania. | Chempluschem | 2025 | 40464701 | PubTator, text mining | PubMed |
| C1QBP promotes apoptosis of goat fetal turbinate cells via inhibiting the expression of TRIM5 or TNFSF10. | Front Vet Sci | 2025 | 40454173 | PubTator, text mining | PubMed |
| C1QBP Modulates DNA Damage Response and Radiosensitivity in Hepatocellular Carcinoma by Regulating NF-κB Activity. | Int J Mol Sci | 2025 | 40429658 | PubTator, text mining | PubMed |
| C1q Binds to CD4+ T Cells and Inhibits the Release of Pro-Inflammatory Cytokines: Role in the Pathogenesis of Systemic Lupus Erythematosus. | Int J Mol Sci | 2025 | 40429614 | PubTator, text mining | PubMed |
| Enhanced delivery of camptothecin to colorectal carcinoma using a tumor-penetrating peptide targeting p32. | Acta Biomater | 2025 | 40379119 | PubTator, text mining | PubMed |
| [The Medical Atom: Radioisotopes in Internal Medicine in the Federal Republic of Germany, 1945-1965]. | NTM | 2025 | 40358679 | PubTator, text mining | PubMed |
| Orchestrated Molecularly Imprinted Nanoparticles for Tumor-Targeted and Chemo-Photothermal Therapy. | ACS Appl Mater Interfaces | 2025 | 40327823 | PubTator, text mining | PubMed |
| Dynamic changes in lactate-related genes in microglia and their role in immune cell interactions after ischemic stroke. | Open Med (Wars) | 2025 | 40292254 | PubTator, text mining | PubMed |
| Corrigendum to "Critical role for heat shock protein 70 in viral replication of ALV-J via interaction with gp37 and P32," [Vet. Microbiol. 303 (2025) 110436]. | Vet Microbiol | 2025 | 40221290 | PubTator, text mining | PubMed |
| Investigating the causal relationships between mitochondrial proteins and dementia with Lewy bodies. | J Alzheimers Dis | 2025 | 40111912 | PubTator, text mining | PubMed |
| Screening and identification of LSDV-specific monoclonal antibodies to establish a double-antibody sandwich ELISA for distinguishing LSDV from SPPV and GTPV. | Int J Biol Macromol | 2025 | 40107527 | PubTator, text mining | PubMed |
| C1QBP Promotes Prostate Cancer Progression and Lipid Accumulation by Negatively Regulating ALDH9A1. | Mol Carcinog | 2025 | 40099576 | PubTator, text mining | PubMed |
| Antigen-presenting fibroblasts: emerging players in immune modulation and therapeutic targets. | Theranostics | 2025 | 40093895 | PubTator, text mining | PubMed |
| Critical role for heat shock protein 70 in viral replication of ALV-J via interaction with gp37 and P32. | Vet Microbiol | 2025 | 39978188 | PubTator, text mining | PubMed |
| Non-canonical ORFs-derived protein products in mitochondria: A multifaceted exploration of their functions in health and disease. | Protein Sci | 2025 | 39969119 | PubTator, text mining | PubMed |
| Integrative pan-cancer genomic analysis highlights mitochondrial protein p32 as a potential therapeutic target in Myc-driven tumorigenesis. | Med Oncol | 2025 | 39891862 | PubTator, text mining | PubMed |
| Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk. | Schizophrenia (Heidelb) | 2025 | 39863625 | PubTator, text mining | PubMed |
| Effects of LinTT1-peptide conjugation on the properties of poly(ethylene glycol)-block-(ε-caprolactone) nanoparticles prepared by the nanoprecipitation method. | Drug Deliv Transl Res | 2025 | 39753999 | PubTator, text mining | PubMed |
| A new peptide inhibitor of C1QBP exhibits potent anti-tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair. | Clin Transl Med | 2025 | 39748215 | PubTator, text mining | PubMed |
| Identification of the whole genome of alternative splicing and RNA-binding proteins involved in nintedanib-induced apoptosis in gastric cancer cells. | PeerJ | 2024 | 39726754 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/papers?page=4